Agilent Technologies Inc
NYSE:A
Relative Value
The Relative Value of one A stock under the Base Case scenario is 162.5025 USD. Compared to the current market price of 137.4675 USD, Agilent Technologies Inc is Undervalued by 15%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
A Competitors Multiples
Agilent Technologies Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Agilent Technologies Inc
NYSE:A
|
40.3B USD | 6 | 32.6 | 26.1 | 31.3 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.6B USD | 5.2 | 37 | 22.8 | 33.5 | ||
US |
Danaher Corp
NYSE:DHR
|
181.8B USD | 7.6 | 38.3 | 25.9 | 36.5 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
42.6B USD | 2.8 | 31.4 | 17 | 26.2 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.9B CHF | 5.6 | 57.9 | 19.9 | 29.2 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
54.8T KRW | 14.8 | 63.9 | 33.7 | 48.5 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.8B USD | 7.1 | 34 | 23.8 | 26.4 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 9.1 | 45.2 | 30.9 | 36.9 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
25.4B USD | 3.1 | 41.4 | 17.6 | 27.4 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
18.9B EUR | 7 | 74.2 | 32 | 52.5 | ||
US |
Illumina Inc
NASDAQ:ILMN
|
19.4B USD | 4.3 | -16.7 | 55.7 | -260.8 |